Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 1:33 PM
Ignite Modification Date:
2025-12-24 @ 1:33 PM
NCT ID:
NCT01418495
Eligibility Criteria:
Inclusion Criteria:
* Diagnosis of high-risk neuroblastoma
* Enrolled on the COG protocol ANBL0032 or ANBL0931 and eligible to receive ch14.18 according to the criteria on these primary treatment protocols
* Parental informed consent and verbal assent of the subject when appropriate
Exclusion Criteria:
* Prior testing demonstrating the presence of HACA
* Anaphylactic reaction to ch14.18 on a prior treatment cycle
Healthy Volunteers:
False
Sex:
ALL
Maximum Age:
15 Years
Study:
NCT01418495
Study Brief:
Protocol Section:
NCT01418495